QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)

Nutrien (NTR) Stock Price, News & Analysis

$54.15
+3.71 (+7.36%)
(As of 02/22/2024 ET)
Today's Range
$51.81
$54.22
50-Day Range
$48.82
$57.49
52-Week Range
$47.90
$83.29
Volume
3.56 million shs
Average Volume
2.02 million shs
Market Capitalization
$26.78 billion
P/E Ratio
12.51
Dividend Yield
3.80%
Price Target
$73.21

Nutrien MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.53 Rating Score
Upside/​Downside
35.2% Upside
$73.21 Price Target
Short Interest
Healthy
0.38% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-5.10
Upright™ Environmental Score
News Sentiment
0.46mentions of Nutrien in the last 14 days
Based on 20 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-0.43%
From $4.66 to $4.64 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.91 out of 5 stars

Basic Materials Sector

3rd out of 173 stocks

Agricultural Chemicals Industry

1st out of 9 stocks


NTR stock logo

About Nutrien Stock (NYSE:NTR)

Nutrien Ltd. provides crop inputs and services. The company operates through Retail, Potash, Nitrogen, and Phosphate segments. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products. The Nitrogen segment offers ammonia, urea, urea ammonium nitrate, industrial grade ammonium nitrate, and ammonium sulfate. The Phosphate segment provides solid fertilizer, liquid fertilizer, and industrial and feed products. In addition, it provides services directly to growers through a network of farm centers in North America, South America, and Australia. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.

NTR Stock Price History

NTR Stock News Headlines

Nutrien reports fall in fourth-quarter profit
Billionaires Are Now FLOODING Into Gold
Ray Dalio, John Paulson, and many others all recommend you own gold right now. But did you know there's another huge investor (worth more than all the world's billionaires COMBINED) buying gold by the ton? That's why the best move to make right now could be this little-known gold investment (which you can get started with for just $5).
Nutrien Reports Fourth Quarter and Full-Year 2023 Results
Nutrien Reports Fourth Quarter and Full-Year 2023 Results
AI Creates New Cancer Drug - In Just 30 Days!
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
What Wall Street expects from Nutrien (Ex Potash Agrium)'s earnings
Nutrien (NTR) to Report Q4 Earnings: What's in the Cards?
Nutrien (NTR) Set to Announce Quarterly Earnings on Wednesday
Why Nutrien Ltd. (TSE:NTR) Could Be Worth Watching
NTR Jan 2026 60.000 put
NTR Jan 2026 40.000 call
NTR Feb 2024 50.000 call
NTR Jan 2024 40.000 put
Nutrien: Buy When There's Blood In The Streets
See More Headlines
Receive NTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutrien and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/12 Dividend
12/28/2023
Dividend Payable
1/12/2024
Last Earnings
2/21/2024
Today
2/22/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
N/A
Employees
24,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$73.21
High Stock Price Target
$99.00
Low Stock Price Target
$58.00
Potential Upside/Downside
+35.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.53
Research Coverage
19 Analysts

Profitability

Net Income
$7.66 billion
Pretax Margin
10.81%

Debt

Sales & Book Value

Annual Sales
$30.93 billion
Cash Flow
$19.27 per share
Book Value
$50.92 per share

Miscellaneous

Free Float
479,270,000
Market Cap
$26.78 billion
Optionable
Optionable
Beta
0.89

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Kenneth A. SeitzMr. Kenneth A. Seitz (Age 54)
    President, CEO & Director
    Comp: $2.25M
  • Mr. Pedro Farah
    Executive VP & CFO
  • Ms. Noralee M. Bradley LLB.
    Executive VP of External Affairs and Chief Sustainability & Legal Officer
  • Mr. Mark Thompson
    Executive VP & Chief Commercial Officer
  • Mr. Jeffrey Martin Tarsi
    Executive VP & President of Global Retail
  • Jeff Holzman
    Vice President of Investor Relations
  • Megan Fielding
    VP of Brand & Culture Communications
  • Andy Kelemen
    Executive VP and Chief of Corporate Development & Strategy Officer
  • Jason Newton
    Head Economist
  • Mr. Trevor Williams
    Executive VP and President of Nitrogen & Phosphate

Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Nutrien was last updated on Tuesday, February 20, 2024 at 10:05 PM.

Pros

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

  • Nutrien Ltd. provides crop inputs and services, operating through Retail, Potash, Nitrogen, and Phosphate segments.
  • The company has a strong network of farm centers in North America, South America, and Australia.
  • Recent developments in the company's operations have shown positive growth potential.
  • The current stock price of Nutrien Ltd. is favorable for potential investors.
  • With its incorporation in 2017 and headquarters in Saskatoon, Canada, Nutrien Ltd. has a solid foundation for future growth.

Cons

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

  • Despite its strengths, Nutrien Ltd. may face challenges in a competitive market environment.
  • Fluctuations in commodity prices could impact the company's profitability.
  • Market uncertainties and global economic conditions may pose risks to Nutrien Ltd.'s performance.
  • Investors should carefully consider the potential risks associated with investing in the agricultural sector.
  • While recent developments have been positive, external factors could influence Nutrien Ltd.'s future prospects.














NTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Nutrien stock right now?

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 9 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NTR shares.
View NTR analyst ratings
or view top-rated stocks.

What is Nutrien's stock price target for 2024?

19 equities research analysts have issued 12-month price objectives for Nutrien's stock. Their NTR share price targets range from $58.00 to $99.00. On average, they expect the company's stock price to reach $73.21 in the next twelve months. This suggests a possible upside of 35.2% from the stock's current price.
View analysts price targets for NTR
or view top-rated stocks among Wall Street analysts.

How have NTR shares performed in 2024?

Nutrien's stock was trading at $56.33 at the beginning of the year. Since then, NTR stock has decreased by 3.9% and is now trading at $54.15.
View the best growth stocks for 2024 here
.

Are investors shorting Nutrien?

Nutrien saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 1,890,000 shares, a decrease of 63.6% from the January 15th total of 5,190,000 shares. Based on an average trading volume of 1,820,000 shares, the short-interest ratio is presently 1.0 days. Approximately 0.4% of the shares of the company are sold short.
View Nutrien's Short Interest
.

When is Nutrien's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our NTR earnings forecast
.

How were Nutrien's earnings last quarter?

Nutrien Ltd. (NYSE:NTR) issued its earnings results on Wednesday, February, 21st. The company reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.72 by $0.35. The firm had revenue of $5.66 billion for the quarter, compared to analysts' expectations of $5.36 billion. Nutrien had a net margin of 7.11% and a trailing twelve-month return on equity of 11.93%. Nutrien's revenue was down 24.8% compared to the same quarter last year. During the same period in the prior year, the business earned $2.02 EPS.

How often does Nutrien pay dividends? What is the dividend yield for Nutrien?

Nutrien declared a quarterly dividend on Wednesday, November 1st. Stockholders of record on Friday, December 29th will be paid a dividend of $0.53 per share on Friday, January 12th. This represents a $2.12 annualized dividend and a yield of 3.92%. The ex-dividend date of this dividend is Thursday, December 28th.
Read our dividend analysis for NTR
.

Is Nutrien a good dividend stock?

Nutrien (NYSE:NTR) pays an annual dividend of $2.06 per share and currently has a dividend yield of 4.04%. NTR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 47.58%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, NTR will have a dividend payout ratio of 44.40% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NTR.

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Who are Nutrien's major shareholders?

Nutrien's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.68%), Mackenzie Financial Corp (2.70%), Parnassus Investments LLC (2.43%), Dodge & Cox (2.32%), First Eagle Investment Management LLC (1.93%) and TD Asset Management Inc (1.87%).

How do I buy shares of Nutrien?

Shares of NTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NTR) was last updated on 2/22/2024 by MarketBeat.com Staff